Proactive Investors - Run By Investors For Investors

ICC International Cannabis Corp recruits long-time cannabis exec David Shpilt as CEO

A pioneer in the cannabis sector, Shpilt was picked to replace outgoing CEO Eugene Beukman, who will remain a director of ICC
cannabis plant
Vancouver-based ICC is developing cultivation platforms for cultivation, extraction, formulation and distribution for cannabis

ICC International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:WLDCF) announced Monday that David Shpilt will come on board as its new CEO.

A pioneer in the cannabis sector, Shpilt was picked to replace outgoing CEO Eugene Beukman, who will remain a director of ICC, after an extensive recruitment process. And his appointment comes as ICC International Cannabis is poised to expand its business internationally, after moving to acquire 49.9% of the international assets and license portfolio of Wayland Group.

Looking ahead, ICC International Cannabis plans to leverage its portfolio of brands as well as its distribution network of over 39,000 European pharmacies to maximize its margins and profitability. It will market and sell CBD products derived from its Swiss, German, Serbian and Croatian industrial hemp inventories as well as reap the benefits of its 2019 cannabis production from its key licenses in the European Union.

READ: ICC International Cannabis continuing with 'buy-and-build' strategy

Throughout his career Shpilt has taken the lead in the cannabis space, having founded over 12 patient clinics across Canada and created genetic libraries of cannabis strains.

On the list of Shpilt’s career highlights is that he has helped to build several contract manufacturing and white-label facilities in Canada, the US and Europe that offer top-line THC (tetrahydrocannabinol) and CBD (cannabidiol) products derived from both cannabis and industrial hemp. He has also successfully orchestrated applications for multiple commercial cannabis licenses under Health Canada’s federal framework for licensed production and developed premium targeted brands for licensed producers, including two cannabis product lines developed to help Canadian military veterans suffering from post-traumatic stress disorder and chronic pain.

READ: ICC International Cannabis, AgraFlora to bring native Colombian cannabis strains to the global market

“David's hands-on abilities operationally, his knowledge of all spheres of the cannabis space, his clear ability to execute and his entrepreneurial nature, along with a demonstrated capacity to lead and delegate in dynamic and growing organizations represent the skill-sets that ICC needs as it moves towards production and sales,” said Eugene Beukman, ICC’s outgoing CEO, in a statement.

For his part, Shpilt also spoke bullishly about his future at ICC International Cannabis.

“Together with International Cannabis, I look forward to the continued enhancement of excellence in cannabis, lifestyle, healthcare and design,” he said in a statement.

Vancouver-based ICC is developing cultivation platforms for cultivation, extraction, formulation and distribution for cannabis and has operating assets in the UK, Europe, Australia, South America and Africa.

Contact Ellen Kelleher at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

Empower clinic locations
March 26 2019
Empower Clinics is one of the largest operators of medical-cannabis-focused healthcare in the US
1541165310_canadian-flag-1.jpg
November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
cannabis plant
March 08 2019
The Vancouver company's recent move into Jamaica, which covers the acquisition of 145 acres of cultivation property, will pave the way for the development of cannabis brands for the island nation
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use